Video

Dr. Jacob Taylor discusses study of imaging modalities for evaluating microhematuria

“The readers of our paper should really understand that in microhematuria specifically, a lot of the recommendations are based on small amounts of data,” says Jacob Taylor, MD, MPH.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Jacob Taylor, MD, MPH, discusses notable findings from the study, “Diagnostic Imaging in the Evaluation of Asymptomatic Microhematuria: Systematic Review and Meta-Analysis.” Taylor is a fellow in urologic oncology at the University of Texas Southwestern Medical Center in Dallas.

      Transcription:

      I think the most notable findings were that the evidence in this space, particularly for microhematuria specifically in the diagnostic work-up for upper tract urothelial carcinoma, is fairly sparse. Out of the thousands of studies that we pulled in our initial review, we reviewed 20 papers for qualitative assessment. Only 6 papers met the necessary criteria, which meant that they had quantitative numbers for us to include in our meta analysis. So the data were pretty small. Only 1 study was included as a point estimate for sensitivity and specificity, evaluating CT urogram in microhematuria patients alone. And in this study, the sensitivity and specificity for upper tract was 80% and 86% respectively. And again, that was just in 1 study. So there were not a lot of data here. The readers of our paper should really understand that in microhematuria specifically, a lot of the recommendations are based on small amounts of data.

      This transcription was edited for clarity.

      Related Content
      © 2025 MJH Life Sciences

      All rights reserved.